What is the technical trend for Nutricircle?

As of May 27, 2025, Nutricircle's technical trend is mildly bearish, with bearish signals from the weekly MACD, Bollinger Bands, and moving averages, while showing slight improvement in monthly momentum indicators.

As of 27 May 2025, the technical trend for Nutricircle has changed from bearish to mildly bearish. The weekly MACD remains bearish, while the monthly MACD is mildly bearish, indicating a slight improvement in momentum. The Bollinger Bands are bearish on both weekly and monthly time frames, suggesting continued downward pressure. Daily moving averages are bearish, reinforcing the negative sentiment. The KST is bearish weekly and mildly bearish monthly, while Dow Theory indicates a mildly bearish stance on both time frames. The RSI shows no signal on both weekly and monthly charts, and the OBV indicates no trend. Overall, the current technical stance is mildly bearish, with key indicators such as MACD and moving averages driving this assessment.

Who are the peers of the Nutricircle?

Nutricircle's peers include Lloyds Enterpris, MMTC, PTC India, and others, with Lloyds showing excellent management and growth, while Nutricircle's 1-year return is -65.72%, significantly lower than Lloyds' 130.59% and MMTC's -24.72%. Overall, management and growth risks vary among peers, with several showing below-average performance.

Peers: The peers of Nutricircle are Lloyds Enterpris, MMTC, PTC India, Optiemus Infra, Halder Venture, W H Brady, JK Agri Genetics, Empower India, and Purv Flexi.<BR><BR>Quality Snapshot: Excellent management risk is observed at Lloyds Enterpris, while Average management risk is found at MMTC, PTC India, Optiemus Infra, Halder Venture, W H Brady, and the rest. Below Average management risk is noted at JK Agri Genetics, Empower India, and Purv Flexi. Growth is Excellent at Lloyds Enterpris, Good at Optiemus Infra, Average at Halder Venture, while Below Average growth is seen at MMTC, PTC India, W H Brady, JK Agri Genetics, Empower India, and Purv Flexi. Capital Structure is Excellent at Lloyds Enterpris, Good at Empower India, and Below Average at MMTC, PTC India, Optiemus Infra, Halder Venture, W H Brady, JK Agri Genetics, and Purv Flexi.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Lloyds Enterpris at 130.59%, while the peer with the lowest is MMTC at -24.72%. Nutricircle's own 1-year return is -65.72%, which is significantly lower than both. Additionally, Empower India and JK Agri Genetics have negative six-month returns.

Who are in the management team of Nutricircle?

As of March 2019, the Nutricircle management team includes Hitesh Patel (Managing Director), Gaurav Shah, Yezdi Batliwala, Minto Gupta, Mohita Gupta (Independent Directors), and Daljeet Kaur (Company Secretary), who collectively guide the company's strategic direction and operations.

As of March 2019, the management team of Nutricircle includes the following individuals:<BR><BR>1. Hitesh Patel - Managing Director<BR>2. Gaurav Shah - Independent Director<BR>3. Yezdi Batliwala - Independent Director<BR>4. Minto Gupta - Director<BR>5. Mohita Gupta - Independent Director<BR>6. Daljeet Kaur - Company Secretary<BR><BR>These members play various roles in guiding the company's strategic direction and operations.

What does Nutricircle do?

Nutricircle Ltd is a micro-cap company in India focused on garment trading, with recent quarterly net sales of 12 Cr and a net profit of 8 Cr. It has a market cap of INR 90 Cr and operates with a P/E ratio of 94.00.

Overview: <BR>Nutricircle Ltd is engaged in the trading of garments in India and operates within the micro-cap market segment.<BR><BR>History: <BR>Nutricircle Ltd, originally incorporated as Shreeyash Industries Limited in 1993, has been involved in garment trading. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>- Net Sales: 12 Cr (Quarterly Results - Mar 2025) <BR>- Net Profit: 8 Cr (Quarterly Results - Mar 2025) <BR>- Market Cap: INR 90 Cr (Micro Cap) <BR><BR>Key Metrics: <BR>- P/E: 94.00 <BR>- Industry P/E: 35 <BR>- Dividend Yield: 0.00% <BR>- Debt Equity: -1.26 <BR>- Return on Equity: -2.77% <BR>- Price to Book: -20.76 <BR><BR>Contact Details: <BR>Address: 5-8-272 276 & 322, Ayesha Residency Public Garden Hyderabad Telangana : 500001 <BR>Tel: 91-22-23202465/40430200 <BR>Email: info@shreeyashindustries.com <BR>Website: https://nutricircle.in

Who are the top shareholders of the Nutricircle?

The top shareholders of Nutricircle are Hitesh Mohan Patel, holding 58.5%, and Ramesh Chandra Mishra, with 11.25%. Individual investors collectively own 41.29%, while there are no mutual funds or foreign institutional investors involved.

The top shareholders of Nutricircle include Hitesh Mohan Patel, who is the promoter with the highest holding at 58.5%. The highest public shareholder is Ramesh Chandra Mishra, holding 11.25%. Additionally, individual investors collectively hold 41.29% of the company's shares. There are no mutual funds or foreign institutional investors currently holding shares in Nutricircle.

How big is Nutricircle?

As of 18th July, Nutricircle Ltd has a market capitalization of 99.00 Cr and reported net sales of 5.31 Cr with a net loss of 0.66 Cr for the latest four quarters. As of March 2024, shareholder's funds are at a loss of 4.33 Cr, with total assets of 1.47 Cr.

As of 18th July, Nutricircle Ltd has a market capitalization of 99.00 Cr, categorizing it as a Micro Cap company.<BR><BR>For the latest four quarters, Nutricircle reported net sales of 5.31 Cr. However, the net profit for the same period showed a loss of 0.66 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, where shareholder's funds are reported at a loss of 4.33 Cr, and total assets amount to 1.47 Cr.

Are Nutricircle latest results good or bad?

Nutricircle's latest results show improved profitability with a Profit After Tax of Rs 0.81 crore for the first half of the fiscal year, up from a loss last year. However, the recent quarterly performance reveals a concerning 96.15% decline in standalone net profit, leading to a downgrade in the company's score and a 'Strong Sell' recommendation.

Nutricircle's latest results present a mixed picture. On one hand, the company has shown a notable improvement in profitability, reporting a Profit After Tax (PAT) of Rs 0.81 crore for the first half of the fiscal year, a significant turnaround from a loss of Rs 1.17 crore in the previous twelve months. This indicates that Nutricircle is making progress in its financial health.<BR><BR>However, when looking at the quarterly performance for the quarter ending June 2025, the results appear less favorable. The company experienced a 75.20% growth in net sales compared to the previous quarter, which is a positive sign. Yet, the standalone net profit saw a drastic decline of 96.15%, which raises concerns about the sustainability of this growth. Additionally, the overall financial performance for the quarter has remained flat, leading to a downgrade in the company's score from 4 to 3, with a 'Strong Sell' recommendation from MarketsMOJO.<BR><BR>In summary, while Nutricircle has made strides in profitability over a six-month period, the recent quarterly results indicate significant challenges that could overshadow these improvements.

Is Nutricircle overvalued or undervalued?

As of September 29, 2025, Nutricircle's valuation has deteriorated to "does not qualify," indicating it is overvalued with a high PE ratio of 176.00 and negative ROCE of -3.24%, especially when compared to peers like PTC India, which has a much lower PE ratio of 7.86.

As of 29 September 2025, Nutricircle's valuation grade has moved from risky to does not qualify, indicating a significant deterioration in its investment appeal. The company is currently overvalued, as evidenced by its high PE ratio of 176.00, an EV to EBIT of 175.42, and a Price to Book Value of 31.87. These ratios suggest that investors are paying a premium for the company's earnings and assets, which may not be justified given its negative return on capital employed (ROCE) of -3.24%.<BR><BR>In comparison to its peers, Nutricircle's valuation metrics stand out unfavorably. For instance, PTC India, classified as very attractive, has a PE ratio of just 7.86 and an EV to EBITDA of 4.15, while MMTC, rated as risky, has a PE ratio of 136.94. This stark contrast highlights Nutricircle's overvaluation relative to its industry. Furthermore, while Nutricircle has shown strong returns over the past five years, outperforming the Sensex significantly, its one-year return of -30.13% raises concerns about its future performance and sustainability at current price levels.

When is the next results date for Nutricircle?

The next results date for Nutricircle is 13 November 2025.

The next results date for Nutricircle is scheduled for 13 November 2025.

How has been the historical performance of Nutricircle?

Nutricircle has faced financial challenges, reporting a loss of -0.82 Cr in March 2016, but has shown gradual improvement with positive shareholder's funds of 5.80 Cr and total assets of 6.72 Cr by March 2025, despite ongoing negative cash flow from operations. The company achieved a net cash inflow of 1.00 Cr through financing activities.

Answer:<BR>The historical performance of Nutricircle shows a challenging financial trajectory, particularly in the fiscal year ending March 2016, where the company reported net sales of 11.54 Cr and a total operating income of 11.54 Cr. However, the total expenditure was significantly higher at 12.38 Cr, leading to an operating profit (PBDIT) of -0.82 Cr and a profit after tax of -0.82 Cr, indicating a loss for the period. The earnings per share (EPS) stood at -1.5, reflecting the company's financial struggles. Over the years, the company's shareholder's funds fluctuated, with a notable recovery to 5.80 Cr by March 2025 from a negative position in previous years. The total assets increased to 6.72 Cr in March 2025, while total liabilities also rose to 6.72 Cr, indicating a balance between assets and liabilities. The cash flow from operating activities remained negative at -3.00 Cr in March 2025, although the company experienced a net cash inflow of 1.00 Cr due to financing activities.<BR><BR>Breakdown:<BR>Nutricircle's financial performance has been marked by significant losses, particularly in March 2016, where it reported a net profit of -0.82 Cr against total sales of 11.54 Cr. The company's operating profit margin was -7.2%, and the profit after tax margin was -7.07%. Over the years, there has been a gradual improvement in shareholder's funds, which turned positive at 5.80 Cr by March 2025, compared to negative values in prior years. The total assets increased to 6.72 Cr in March 2025, matching total liabilities, which also stood at 6.72 Cr. Despite these improvements, the cash flow from operating activities remained negative at -3.00 Cr in March 2025, although the company managed to achieve a net cash inflow of 1.00 Cr through financing activities, indicating some recovery in its financial position.

Should I buy, sell or hold Nutricircle?

Which are the latest news on Nutricircle?

Why is Nutricircle falling/rising?

As of 14-Dec, Nutricircle Ltd's stock price is at Rs. 309.05, reflecting a 2.0% increase and reaching a new all-time high. Despite strong short-term performance and significant outperformance against the Sensex, concerns remain regarding the company's long-term fundamentals.

As of 14-Dec, Nutricircle Ltd's stock price is rising, currently at Rs. 309.05, reflecting a change of 6.05 (2.0%) upwards. The stock has shown significant performance over various periods, with a remarkable increase of 31.51% over the last eight days, indicating a strong upward trend. Additionally, it has outperformed the sector by 1.06% today and reached a new 52-week and all-time high of Rs. 309.05.<BR><BR>The stock's performance relative to the benchmark, Sensex, has been impressive, with a 1-week return of +13.62% compared to Sensex's -0.52%, and a 1-month return of +45.09% against Sensex's +0.95%. Over the past year, Nutricircle has generated a return of 37.36%, significantly outperforming the Sensex's 4.89%. Furthermore, the stock is trading above its moving averages across multiple time frames, indicating strong momentum.<BR><BR>However, it is important to note that there are concerns regarding the company's long-term fundamental strength, with a low Return on Capital Employed (ROCE) of 2.13% and a high Debt to EBITDA ratio. Despite these weaknesses, the current price rise can be attributed to short-term market dynamics and investor sentiment, as evidenced by the stock's recent gains and strong performance metrics.